Teyame.AI

Healthcare Triangle (HCTI) unveiled a strategy to reshape its scale and capital, including acquiring Teyame.AI, a $34M revenue platform which doubles HCTI’s market cap. HCTI is marketing its QuantumNexis GenAI SaaS and exploring acquisitions like Niyama and Ezovion. A warrant inducement program lowered warrant strike prices to $2.00 and issued new warrants at $3.00. HCTI’s stock traded at $2.84 on October 13, 2025, up over 31% since September, driven by its strategic move to AI-driven patient engagement and data solutions.